Mingze Qin

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 9

Top Venues

EMBO molecular medicine

Journal of medicinal chemistry

Shenyang Pharmaceutical University

Shenyang Pharmaceutical University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Shenyang Pharmaceutical University Jan 01 2018

China

Associate professor :: School of Pharmaceutical Engineering

Education History

Shenyang Pharmaceutical University

China

PHD :: School of Pharmaceutical Engineering

Publications

Yuan Yang, Zefei Li, Yidong Wang, Jiwei Gao, Yangyang Meng, Simeng Wang, Xiaoyao Zhao, Chengfang Tang, Weiming Yang, Yingjia Li, Jie Bao, Xinyu Fan, Jing Tang, Jingyu Yang, Chunfu Wu, Mingze Qin, Lihui Wang
The regulatory relationship between NAMPT and PD-L1 in cancer and identification of a dual-targeting inhibitor. EMBO molecular medicine 16 (4) (2024)
Yuan Yang, Zefei Li, Yidong Wang, Jiwei Gao, Yangyang Meng, Simeng Wang, Xiaoyao Zhao, Chengfang Tang, Weiming Yang, Yingjia Li, Jie Bao, Xinyu Fan, Jing Tang, Jingyu Yang, Chunfu Wu, Mingze Qin, Lihui Wang
The regulatory relationship between NAMPT and PD-L1 in cancer and identification of a dual-targeting inhibitor. EMBO molecular medicine 16 (4) (2024)
Yuan Yang, Zefei Li, Yidong Wang, Jiwei Gao, Yangyang Meng, Simeng Wang, Xiaoyao Zhao, Chengfang Tang, Weiming Yang, Yingjia Li, Jie Bao, Xinyu Fan, Jing Tang, Jingyu Yang, Chunfu Wu, Mingze Qin, Lihui Wang
The regulatory relationship between NAMPT and PD-L1 in cancer and identification of a dual-targeting inhibitor. EMBO molecular medicine (2024)
Yuan Yang, Zefei Li, Yidong Wang, Jiwei Gao, Yangyang Meng, Simeng Wang, Xiaoyao Zhao, Chengfang Tang, Weiming Yang, Yingjia Li, Jie Bao, Xinyu Fan, Jing Tang, Jingyu Yang, Chunfu Wu, Mingze Qin, Lihui Wang
The regulatory relationship between NAMPT and PD-L1 in cancer and identification of a dual-targeting inhibitor. EMBO molecular medicine 16 (4) (2024)
Yuan Yang, Zefei Li, Yidong Wang, Jiwei Gao, Yangyang Meng, Simeng Wang, Xiaoyao Zhao, Chengfang Tang, Weiming Yang, Yingjia Li, Jie Bao, Xinyu Fan, Jing Tang, Jingyu Yang, Chunfu Wu, Mingze Qin, Lihui Wang
The regulatory relationship between NAMPT and PD-L1 in cancer and identification of a dual-targeting inhibitor. EMBO molecular medicine 16 (4) (2024)
Xiaoyi Zeng, Yajing Liu, Yuxin Fan, Di Wu, Yangyang Meng, Mingze Qin
Agents for the Treatment of Gout: Current Advances and Future Perspectives. Journal of medicinal chemistry (2023)
Yangyang Meng, Yidong Wang, Shaopeng Zhang, Yuan Yang, Di Wu, Wei Cui, Xinyu Niu, Cuiping Chu, Lihui Wang, Mingze Qin
Novel 4-Arylindolines Containing a Pyrido[3,2- d ]pyrimidine Moiety as the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Interaction Inhibitors for Tumor Immunotherapy. Journal of medicinal chemistry (2023)
Mingze Qin, Yangyang Meng, Haoshen Yang, Lei Liu, Haotian Zhang, Simeng Wang, Chunyang Liu, Xia Wu, Di Wu, Ye Tian, Yunlei Hou, Yanfang Zhao, Yajing Liu, Congjun Xu, Lihui Wang
Discovery of 4-Arylindolines Containing a Thiazole Moiety as Potential Antitumor Agents Inhibiting the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Interaction. Journal of medicinal chemistry 64 (9) (2021)
Mingze Qin, Qi Cao, Shuaishuai Zheng, Ye Tian, Haotian Zhang, Jun Xie, Hongbo Xie, Yajing Liu, Yanfang Zhao, Ping Gong
Discovery of [1,2,4]Triazolo[4,3- a]pyridines as Potent Inhibitors Targeting the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Interaction. Journal of medicinal chemistry 62 (9) (2019)

Mingze Qin.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Mingze Qin